cprx stock price forecast
Continued to forecast full year 2022 total revenues to be in the. 4 analysts have issued 1 year target prices for Catalyst Pharmaceuticals stock.
If You Had Bought Catalyst Pharmaceuticals Nasdaq Cprx Stock Five Years Ago You Could Pocket A 43 Gain Today
According to the issued ratings of 4 analysts in the last year the consensus rating for Catalyst Pharmaceuticals stock is Buy based on the current 4 buy ratings for CPRX.
. Searching for Financial Security. Ad Ensure Your Investments Align with Your Goals. CPRX analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.
CPRX Stock Analysis Overview. Weve Helped Investors Just Like You Achieve Tremendous Gains In The Stock Market. Catalyst Pharm Inc CPRX gets an Overall Rank of 75 which is an above average rank under InvestorsObservers stock ranking.
Meanwhile note that the median CPRX forecast price target median being the middle where half of analysts had a higher CPRX forecast and half had a lower CPRX forecast which is a. Find the latest Catalyst Pharmaceuticals Inc CPRX stock price forecast 12-month price target predictions and analyst recommendations. Find the latest analyst research for Catalyst Pharmaceuticals Inc.
---March 9 2022 356 PM EST. Find the latest Catalyst Pharmaceuticals Inc. According to 11 analysts the average rating for CPRX stock is Buy The 12-month stock price forecast is 1117 which is an increase of 3876 from the.
Find a Dedicated Financial Advisor Now. Stock Market News - Financial News - MarketWatch. Real time Catalyst Pharmaceuticals CPRX stock price quote stock graph news analysis.
Stock Price Forecast The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1200 and a low. Given the current short-term trend the stock is expected to rise 755 during the next 3 months and with a 90 probability hold a price between 769 and 939 at the end of. Ad We Find Penny Stocks We Think Are About To Explode And Email You An Alert.
Analyst estimates including CPRX earnings per share estimates and analyst recommendations. What is CPRXs Earnings Per Share. Their forecasts range from 875 to 1200.
Based on analysts offering 12 month price targets. US Markets Close In 3 min. For Catalyst Pharmaceuticals stock forecast for 2022 8 predictions are offered for each month of 2022 with average Catalyst Pharmaceuticals stock forecast of 814 a high forecast of 83.
The average CATALYST PHARMACEUTICALS stock price prediction forecasts a potential upside of 6885 from the current CPRX share price of 687. The 5 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 1200 with a high estimate of 1500 and a low. CPRX stock quote history news and other vital information to help you with your stock trading and investing.
Catalyst Pharmaceuticals Inc Stock Forecast CPRX Stock Predictons by days. Common Stock CPRX. - Try Now Risk-Free - Money-back guarantee.
Catalyst Pharmaceuticals Inc. About the Catalyst Pharmaceuticals Inc. Our Financial Advisors Offer a Wealth of Knowledge.
As of 2022 May 26 Thursday current price of CPRX stock is 6890 and our data indicates that the asset price has. Catalyst Pharmaceuticals Stock Prediction. Get Our PREMIUM Forecast Now from ONLY 849.
The Catalyst Pharmaceuticals stock price gained 202 on the last trading day Friday 20th May 2022 rising from 692 to 706. Provides Revenue Guidance for the Year 2022. And has now gained 3 days in a rowIt will.
Todays 52-Week Highs. On average they expect Catalyst Pharmaceuticals. Catalyst Pharmaceuticals Inc.
Find the latest Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Cprx Q1 Earnings Miss Revenues Up Y Y Nasdaq
Catalyst Cprx Q4 Earnings Lag Estimates Revenues Rise Y Y Nasdaq
Catalyst Pharmaceuticals Stock Forecast Up To 8 044 Usd Cprx Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis
Here S Why We Think Catalyst Pharmaceuticals Nasdaq Cprx Is Well Worth Watching Nasdaq
Catalyst Pharmaceuticals Inc The Big Breakout Cprx Stock Forecast Cprx Stock Analysis Cprx In 2022 Stock Analysis Analysis Trend Analysis
Analysts Just Shipped A Substantial Upgrade To Their Catalyst Pharmaceuticals Inc Nasdaq Cprx Estimates
Catalyst S Cprx Stock Up On 2022 Guidance For Firdapse Nasdaq
Catalyst Pharmaceuticals Has Potential To Push Higher If They Can Overcome Current Headwinds Nasdaq Cprx Seeking Alpha
Cprx Short Interest Catalyst Pharmaceuticals Inc Stock Short Squeeze Short Sale Volume Borrow Rates Fails To Deliver
Zacks Analysts Anticipate Catalyst Pharmaceuticals Inc Nasdaq Cprx Will Announce Earnings Of 0 14 Per Share Defense World
Catalyst Pharmaceuticals Has Potential To Push Higher If They Can Overcome Current Headwinds Nasdaq Cprx Seeking Alpha
Crypto Perx Price Prediction Cprx Forecast 2023 2024 2025 2026 2027 2028
Catalyst Pharmaceutical Inc Share Price Com Stk Usd0 001
Cprx Youtube
Catalyst Pharmaceuticals Has Potential To Push Higher If They Can Overcome Current Headwinds Nasdaq Cprx Seeking Alpha
Cprx Stock Forecast 2022 2025 Expert Analysis Coin Decimal
Is Cprx A Good Stock To Buy Now
Catalyst Pharmaceuticals Nasdaqcm Cprx Share Price News Analysis Simply Wall St
Bayer Bayry Earnings Revenues Surpass Estimates In Q4 Nasdaq